Predicting Resistance to Immunotherapy in Melanoma, Glioblastoma, Renal, Stomach and Bladder Cancers by Machine Learning on Immune Profiles.

MLA

Mestrallet, Guillaume. “Predicting Resistance to Immunotherapy in Melanoma, Glioblastoma, Renal, Stomach and Bladder Cancers by Machine Learning on Immune Profiles.” Onco, vol. 4, no. 3, Sept. 2024, pp. 192–206. EBSCOhost, https://doi.org/10.3390/onco4030014.

APA

Mestrallet, G. (2024). Predicting Resistance to Immunotherapy in Melanoma, Glioblastoma, Renal, Stomach and Bladder Cancers by Machine Learning on Immune Profiles. Onco, 4(3), 192–206. https://doi.org/10.3390/onco4030014

Chicago

Mestrallet, Guillaume. 2024. “Predicting Resistance to Immunotherapy in Melanoma, Glioblastoma, Renal, Stomach and Bladder Cancers by Machine Learning on Immune Profiles.” Onco 4 (3): 192–206. doi:10.3390/onco4030014.